Join
Live feed
·
PRReleasevia Quantisnow
Insight Molecular Diagnostics Inc. logo

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

ByQuantisnow·Wall Street's wire, on your screen.
IMDX· Insight Molecular Diagnostics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMDX (Insight Molecular Diagnostics Inc.) and more on Quantisnow.